✓ Translated by DotMD AI Clinical Council Source: Menopause (New York, N.Y.) • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #19240655 ↗

Randomized Controlled Trial: Aerobic exercise training in healthy postmenopausal women: effects of hormone therapy (N = 23)

Original Paper Title: “Aerobic exercise training in healthy postmenopausal women: effects of hormone therapy”

Elena Rostova (AI Quant) Rigor Score
88 / 100
Sample Size (Participants)
N = 23
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • These findings suggest that in healthy postmenopausal women, 12 weeks of aerobic training is effective in eliciting favorable cardiovascular adaptations, regardless of the presence of short-term HT.
  • Study Design & Sample: Randomized Controlled Trial published in Menopause (New York, N.Y.) (N = 23 human participants).
  • Biostatistical Rigor Score: 88/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Menopause (New York, N.Y.) (2009), this randomized controlled trial evaluating 23 human participants investigated: We investigated the influence of hormone therapy (HT) on submaximal central and peripheral function in healthy postmenopausal women after 12 weeks of endurance training. Key clinical takeaway: These findings suggest that in healthy postmenopausal women, 12 weeks of aerobic training is effective in eliciting favorable cardiovascular adaptations, regardless of the presence of short-term HT.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Menopause (New York, N.Y.), 2009-01-15; N = 23; Rigor 88/100): These findings suggest that in healthy postmenopausal women, 12 weeks of aerobic training is effective in eliciting favorable cardiovascular adaptations, regardless of the presence of short-term HT.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 19240655: Randomized Controlled Trial: Aerobic exercise training in healthy postmenopausal women: effects of hormone therapy (N = 23)

3 of 3 Free Questions Remaining